Unit
Gastroenterology/Hepatology
GASTRO · Dept. I
Unspecific abdominal symptoms and pneumobilia: a rare case of gastrointestinal obstruction
Keller M, Epp C, Meyenberger C, Sulz M. Unspecific abdominal symptoms and pneumobilia: a rare case of gastrointestinal obstruction. Case Reports in Gastroenterology 2014:216-220.
Jun 14, 2014Unspecific abdominal symptoms and pneumobilia: a rare case of gastrointestinal obstruction
Jun 14, 2014Case Reports in Gastroenterology 2014:216-220
Keller Martina, Epp Carola, Meyenberger Christa, Sulz Michael
Unspecific abdominal symptoms and pneumobilia: a rare case of gastrointestinal obstruction
Keller M, Epp C, Meyenberger C, Sulz M. Unspecific abdominal symptoms and pneumobilia: a rare case of gastrointestinal obstruction. Case Rep Gastroenterol 2014; 8:216-20.
Jun 14, 2014Unspecific abdominal symptoms and pneumobilia: a rare case of gastrointestinal obstruction
Jun 14, 2014Case Rep Gastroenterol 2014; 8:216-20
Keller Martina, Epp Carola, Meyenberger Christa, Sulz Michael
The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota
Balmer M, McCoy K, Heim M, Dickgreber N, Stroka D, Wyss M, Ronchi F, Bernsmeier C, Patuto N, Fahrner R, Van Vlierberghe H, Grieco A, Miele L, Hapfelmeier S, Lawson M, De Gottardi A, Slack E, Macpherson A. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med 2014; 6:237ra66.
May 21, 2014The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota
May 21, 2014Sci Transl Med 2014; 6:237ra66
Balmer Maria L, McCoy Kathy D, Heim Markus H, Dickgreber Nina, Stroka Deborah, Wyss Madeleine, Ronchi Francesca, Bernsmeier Christine, Patuto Nicola, Fahrner René, Van Vlierberghe Hans, Grieco Antonio, Miele Luca, Hapfelmeier Siegfried, Lawson Melissa A E, De Gottardi Andrea, Slack Emma, Macpherson Andrew J
Strategies to manage hepatitis C virus (HCV) disease burden
Kautz A, Myers R, Nemecek V, Øvrehus A, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Roberts S, Mullhaupt B, Moreno C, Mendes Correa M, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha G, Sperl J, Stärkel P, Stauber R, Thompson A, Gower E, Kaita K, Wedemeyer H, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Calinas F, Calleja J, Cheinquer H, Christensen P, Berg T, Balık I, Aleman S, Duberg A, Buti M, Rosenberg W, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H, Gerstoft J, Giria J, Gonçales F, Guimarães Pessôa M, Hézode C, Hindman S, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P, Ferraz M, Cornberg M, Cramp M, Dore G, Doss W, El-Sayed M, Ergör G, Estes C, Falconer K, Félix J, Kåberg M. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21 Suppl 1:60-89.
May 1, 2014Strategies to manage hepatitis C virus (HCV) disease burden
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:60-89
Kautz A, Myers R P, Nemecek V, Øvrehus A L H, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Roberts S K, Mullhaupt B, Moreno C, Mendes Correa M C, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R T, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S D, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela David, Sherman M, Shiha G E, Sperl J, Stärkel P, Stauber R E, Thompson A J, Gower E, Kaita K D E, Wedemeyer H, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Berg T, Balık I, Aleman S, Duberg A S, Buti M, Rosenberg W M, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H S M, Gerstoft J, Giria J A, Gonçales F L, Guimarães Pessôa M, Hézode C, Hindman S J, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P R, Ferraz M L G, Cornberg M, Cramp M E, Dore G J, Doss W, El-Sayed M H, Ergör G, Estes C, Falconer K, Félix J, Kåberg M
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Kaita K, Nemecek V, Örmeci N, Øvrehus A, Parkes J, Pasini K, Peltekian K, Ramji A, Reis N, Roberts S, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R, Marotta P, Mauss S, Rosenberg W, Roudot-Thoraval F, Ryder S, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela D, Sherman M, Shiha G, Sievert W, Sperl J, Stärkel P, Stauber R, Thompson A, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Buti M, Calleja J, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R, Idilman R, Calinas F, Vogel W, Mendes Correa M, Hézode C, Lázaro P, Christensen P, Clausen M, Coelho H, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S, Hofer H, Frankova S, Ferreira P, Ferraz M, Cramp M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Falconer K, Félix J, Husa P. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014; 21 Suppl 1:34-59.
May 1, 2014The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:34-59
Kaita K D E, Nemecek V, Örmeci N, Øvrehus A L H, Parkes J, Pasini K, Peltekian K M, Ramji A, Reis N, Roberts S K, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R T, Marotta P, Mauss S, Rosenberg W M, Roudot-Thoraval F, Ryder S D, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela David, Sherman M, Shiha G E, Sievert W, Sperl J, Stärkel P, Stauber R E, Thompson A J, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Buti M, Calleja J L, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R P, Idilman R, Calinas F, Vogel W, Mendes Correa M C, Hézode C, Lázaro P, Christensen P B, Clausen M, Coelho H S M, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S J, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Cramp M E, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Falconer K, Félix J, Husa P
Historical epidemiology of hepatitis C virus (HCV) in selected countries
Kåberg M, Myers R, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M, Mauss S, Kaita K, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S, Rosenberg W, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela D, Shiha G, Sievert W, Stärkel P, Stauber R, Thompson A, Urbanek P, Hindman S, Idilman R, Bruggmann P, Bilodeau M, Blasco A, Buti M, Calinas F, Calleja J, Cheinquer H, Christensen P, Clausen M, Coelho H, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A, Moreno C, Brandão Mello C, Roudot-Thoraval F, Marinho R, Sherman M, Ryder S, Sperl J, Cornberg M, Cramp M, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P, Ferraz M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014; 21 Suppl 1:5-33.
May 1, 2014Historical epidemiology of hepatitis C virus (HCV) in selected countries
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:5-33
Kåberg M, Myers R P, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M C, Mauss S, Kaita K D E, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S K, Rosenberg W M, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela David, Shiha G E, Sievert W, Stärkel P, Stauber R E, Thompson A J, Urbanek P, Hindman S J, Idilman R, Bruggmann P, Bilodeau M, Blasco A J, Buti M, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Clausen M, Coelho H S M, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A L H, Moreno C, Brandão Mello C E, Roudot-Thoraval F, Marinho R T, Sherman M, Ryder S D, Sperl J, Cornberg M, Cramp M E, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies
Beigel F, Brand S, Seiderer J, Göke B, Laubender R, Van Steen K, John J, Breiteneicher S, Tillack C, Schnitzler F, Steinborn A, Ochsenkühn T. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies. Pharmacoepidemiol Drug Saf 2014; 23:735-44.
Apr 30, 2014Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies
Apr 30, 2014Pharmacoepidemiol Drug Saf 2014; 23:735-44
Beigel Florian, Brand Stephan, Seiderer Julia, Göke Burkhard, Laubender Rüdiger P, Van Steen Kristel, John Jestinah Mahachie, Breiteneicher Simone, Tillack Cornelia, Schnitzler Fabian, Steinborn Anni, Ochsenkühn Thomas
Routine use of Hemospray for gastrointestinal bleeding: prospective two-center experience in Switzerland
Sulz M, Frei R, Meyenberger C, Bauerfeind P, Semadeni G, Gubler C. Routine use of Hemospray for gastrointestinal bleeding: prospective two-center experience in Switzerland. Endoscopy 2014
Apr 25, 2014Routine use of Hemospray for gastrointestinal bleeding: prospective two-center experience in Switzerland
Apr 25, 2014Endoscopy 2014
Sulz Michael, Frei Remus, Meyenberger Christa, Bauerfeind Peter, Semadeni Gian-Marco, Gubler Christoph
Differentiation of focal liver lesions - Accuracy of contrast-enhanced ultrasound in comparison with CT/MRI in a tertiary Swiss GI center
Sawatzki M (2014). Differentiation of focal liver lesions - Accuracy of contrast-enhanced ultrasound in comparison with CT/MRI in a tertiary Swiss GI center.
Apr 11, 2014Differentiation of focal liver lesions - Accuracy of contrast-enhanced ultrasound in comparison with CT/MRI in a tertiary Swiss GI center
Apr 11, 2014EASL
Sawatzki Mikael
Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members
Beigel F, Friedrich M, Probst C, Sotlar K, Göke B, Diegelmann J, Brand S. Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members. PloS one 2014; 9:e93498.
Apr 7, 2014Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members
Apr 7, 2014PloS one 2014; 9:e93498
Beigel Florian, Friedrich Matthias, Probst Corina, Sotlar Karl, Göke Burkhard, Diegelmann Julia, Brand Stephan
Protective mucosal immunity mediated by epithelial CD1d and IL-10
Olszak T, Nakajima A, Mizuguchi H, Kawasaki K, Nagata K, Müller W, Snapper S, Schreiber S, Kaser A, Zeissig S, Katayama K, Wada K, Neves J, Dowds C, Baker K, Glickman J, Davidson N, Lin C, Jobin C, Brand S, Sotlar K, Blumberg R. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 2014; 509:497-502.
Apr 6, 2014Protective mucosal immunity mediated by epithelial CD1d and IL-10
Apr 6, 2014Nature 2014; 509:497-502
Olszak Torsten, Nakajima Atsushi, Mizuguchi Hiroyuki, Kawasaki Kunito, Nagata Kazuhiro, Müller Werner, Snapper Scott B, Schreiber Stefan, Kaser Arthur, Zeissig Sebastian, Katayama Kazufumi, Wada Koichiro, Neves Joana F, Dowds C Marie, Baker Kristi, Glickman Jonathan, Davidson Nicholas O, Lin Chyuan-Sheng, Jobin Christian, Brand Stephan, Sotlar Karl, Blumberg Richard S
[Malignant hypoglycaemia]
Rigger J, Kleger G, Semela D, Doenecke C, Rodriguez R, Meyenberger C, Köberle D, Sawatzki M. [Malignant hypoglycaemia]. Praxis (Bern 1994) 2014; 103:399-403.
Mar 26, 2014[Malignant hypoglycaemia]
Mar 26, 2014Praxis (Bern 1994) 2014; 103:399-403
Rigger Johannes, Kleger Gian-Reto, Semela David, Doenecke Christian, Rodriguez Regulo, Meyenberger Christa, Köberle Dieter, Sawatzki Mikael
Vom Pneumoperitoneum zum Pneumothorax
Baumann P. Vom Pneumoperitoneum zum Pneumothorax. 2014
Mar 25, 2014Vom Pneumoperitoneum zum Pneumothorax
Mar 25, 20142014
Baumann Philippe
The contribution of intrabolus pressure to symptoms induced by gastric banding
Preissler C, Krieger-Grübel C, Borovicka J, Fried M, Tutuian R. The contribution of intrabolus pressure to symptoms induced by gastric banding. J Gastrointestin Liver Dis 2014; 23:13-7.
Mar 1, 2014The contribution of intrabolus pressure to symptoms induced by gastric banding
Mar 1, 2014J Gastrointestin Liver Dis 2014; 23:13-7
Preissler Claudia, Krieger-Grübel Claudia, Borovicka Jan, Fried Michael, Tutuian Radu
Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure
Antoniades C, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Goldin R, Gilroy D, Khamri W, Abeles R, Taams L, Triantafyllou E, Possamai L, Bernsmeier C, Mitry R, O'Brien A, Thursz M. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology 2014; 59:1564-76.
Feb 28, 2014Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure
Feb 28, 2014Hepatology 2014; 59:1564-76
Antoniades Charalambos Gustav, Heneghan Michael, Heaton Nigel, Jassem Wayel, Bernal William, Vergani Diego, Ma Yun, Quaglia Alberto, Wendon Julia, Goldin Robert, Gilroy Derek, Khamri Wafa, Abeles Robin D, Taams Leonie S, Triantafyllou Evangelos, Possamai Lucia A, Bernsmeier Christine, Mitry Ragai R, O'Brien Alistair, Thursz Mark
How is the increased risk of colorectal cancer in first-degree relatives of patients communicated?
Sulz M, Meyenberger C, Sawatzki M. How is the increased risk of colorectal cancer in first-degree relatives of patients communicated?. Eur J Gastroenterol Hepatol 2014; 26:222-8.
Feb 1, 2014How is the increased risk of colorectal cancer in first-degree relatives of patients communicated?
Feb 1, 2014Eur J Gastroenterol Hepatol 2014; 26:222-8
Sulz Michael, Meyenberger Christa, Sawatzki Mikael
Maligne Hypoglykämie
Rigger J, Kleger G, Semela D, Doenecke C, Rodriguez R, Meyenberger C, Köberle D, Sawatzki M. Maligne Hypoglykämie. Praxis 2014; 103 (7):399-403.
Feb 1, 2014Maligne Hypoglykämie
Feb 1, 2014Praxis 2014; 103 (7):399-403
Rigger Johannes, Kleger Gian Reto, Semela David, Doenecke Christian, Rodriguez Regulo, Meyenberger Christa, Köberle Dieter, Sawatzki Mikael
[Colorectal screening makes sense]
Sulz M. [Colorectal screening makes sense]. Praxis (Bern 1994) 2014; 103:123.
Jan 29, 2014[Colorectal screening makes sense]
Jan 29, 2014Praxis (Bern 1994) 2014; 103:123
Sulz Michael
Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease
Bernsmeier C, Meyer-Gerspach A, Blaser L, Jeker L, Steinert R, Heim M, Beglinger C. Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease. PloS one 2014; 9:e87488.
Jan 29, 2014Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease
Jan 29, 2014PloS one 2014; 9:e87488
Bernsmeier Christine, Meyer-Gerspach Anne C, Blaser Lea S, Jeker Lia, Steinert Robert E, Heim Markus H, Beglinger Christoph
Autoimmunhepatitis
Sulz M, Gerlach T. Autoimmunhepatitis - So diagnostizieren und behandeln Sie richtig. Hausarztpraxis 2013:10-14.
Dec 10, 2013Autoimmunhepatitis
Dec 10, 2013Hausarztpraxis 2013:10-14
Sulz Michael, Gerlach Tilman